compounded semaglutide ban FDA moves to remove GLP-1 medications from 503B Bulks List Trade group opposes Novo Nordisk's
Pay in 4 interest-free payments of $6.17 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30




![Ad hoc announcement pursuant to Art. 53 LR] Roche announces positive Phase I results of its oral GLP-1 receptor agonist CT-996 for the treatment of people with obesity](https://a.storyblok.com/f/176343/1920x1281/8abca57422/roche_270585.jpeg)













